TRANSFORMATION BY AVIAN RETICULOENDOTHELIOSIS VIRUS
TRANSFORMATION BY AVIAN RETICULOENDOTHELIOSIS VIRUS
批准号:
6375651
负责人:
HENRY R BOSE
金额:
$29.82万
依托单位国家:
美国
项目类别:
财政年份:
1984
资助国家:
美国
项目状态:
已结题
起止时间:
1984-01-01 至 2005-06-30
中文摘要
描述:(改编自《调查者摘要》):禽类
网状内皮组织增生症病毒(REV-T)是所有逆转录病毒中毒力最强的
很快就会导致致命的淋巴瘤。V-Rel是致癌性最强的
Rel/NF-KB转录因子家族的成员。REI/NF-KB家族
调节与增殖、凋亡、防御有关的基因的表达
以及伤口愈合反应和胚胎发育。REI/NF-KB复合体与
DNA识别基序为二聚体。V-rel的转换是以下结果
对通常由REI/NF-KB家族控制的基因的差异调控。
在转化细胞的细胞核中,v-rel以同源二聚体或
含有c-REI、NF-KBL和NF-KB2的杂二聚体。自从……出现以来
核内V-受体异源二聚体在时间上与细胞内
细胞增殖率、v-Rel与内源性REI/NF-KB的关系
家庭成员很可能在它的转型能力中发挥关键作用。
我们已经分离出了v-rel的点突变,它们已经失去了
与特定的REI/NF-KB家庭成员联系,并建议聘用这些成员
点突变以确定哪些REI/NF-KB家族成员使v-REL能够
变形。
V-rel的过度表达导致c-fos和c-fos的表达升高
C-jun和Fra-2在成纤维细胞培养和淋巴组织中的抑制表达
细胞。C-jun已经被证明是直接转录上调的
V-REI。成纤维细胞培养物或淋巴样细胞的混合感染或顺序感染
逆转录病毒表达v-rel和一个转显性负性突变体的细胞
AP-1活性,supjun-1,导致转化减少
V-REL的效率。这些研究没有定义单个AP-1的作用
家庭成员。C-jun、c-fos和fra-2在v-Rel介导中的作用
我们将对转型进行考察。我们还建议确定V-Rel是否
直接调控c-fos和fra-2的差异表达。
最近,我们发现Rho家族小分子GTP酶家族的成员TClO,
在v-Rel转化的成纤维细胞中上调。由于TCIO和其他RHO
蛋白质与肌动蛋白细胞骨架的组织有关,它
TC10介导的信号转导通路可能是
成纤维细胞中观察到的细胞骨架重塑
通过v-Rel进行变换。此外,TCIO还激活c-jun氨基末端激酶
(JNK),它磷酸化并激活c-jun。因此,V-Rel可以调节
AP-1的活性不仅在转录水平上,而且在
翻译后水平通过TC1O激活途径。的最终目标是
这项提议是为了确定TCIO是否在v-REI介导的过程中发挥作用
转型。
英文摘要
DESCRIPTION: (Adapted from the Investigator's abstract):Avian
reticuloendotheliosis virus (REV-T) is the most virulent of all retroviruses
and rapidly induces an invariably fatal lymphoma. v-Rel is the most oncogenic
member of the Rel/NF-KB family of transcription factors. The ReI/NF-KB family
regulates the expression of genes involved in proliferation, apoptosis, defense
and wound healing responses, and embryogenesis. The ReI/NF-KB complexes bind to
DNA recognition motifs as dimers. Transformation by v-Rel is the result of
differential regulation of genes normally controlled by the ReI/NF-KB family.
In the nuclei of transformed cells, v-Rel exists as homodimers or in
heterodimers with c-ReI, NF-KBl, and NF-KB2. Since the appearance of
v-Relheterodimers in the nucleus temporally correlates with an increase in the
rate of cell proliferation, the association of v-Rel with endogenous ReI/NF-KB
family members is likely to play a critical role in its transforming ability.
We have isolated point mutants of v-Rel which have lost their ability to
associate with specific ReI/NF-KB family members and propose to employ these
point mutants to determine which ReI/NF-KB family members enable v-Rel to
transform.
The overexpression of v-Rel, results in the elevated expression of c-fos and
c-jun and in repressed expression of fra-2 in fibroblast cultures and lymphoid
cells. c-jun has been shown to be directly transcriptionally upregulated by
v-ReI. Co-infection or sequential infection of fibroblast cultures or lymphoid
cells with retroviruses expressing v-rel and a transdominant negative mutant of
AP-1 activity, supjun-1, resulted in a reduction of the transformation
efficiency of v-Rel. These studies did not define the role of individual AP-1
family members. The role of c-Jun, c-fos, and fra-2 in v-Rel-mediated
transformation will be examined. We also propose to determine whether v-Rel
directly regulates the differential expression of c-fos and fra-2.
Recently, we have found that TClO, a member of the Rho family of small GTPases,
is upregulated in v-Rel transformed fibroblasts. Since TCIO and other Rho
proteins have been implicated in the organization of the actin cytoskeleton, it
is possible that the TC1O-mediated signal transduction pathway may be
responsible for the cytoskeletal remodeling observed in fibroblast
transformation by v-Rel. In addition, TCIO activates c-Jun N-terminal kinase
(JNK) which phosphorylates and activates c-Jun. v-Rel may, therefore, regulate
AP-1 activity not only at the transcriptional level, but also at the
post-translational level through the TC1O activation pathway. The last aim of
this proposal is to determine if TCIO plays a role in v-ReI-mediated
transformation.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Mechanism of oncogenesis by Rel/NF-kappaB
-
批准号:7041732
-
项目类别:
-
资助金额:$5.66万
-
财政年份:2003
-
负责人:HENRY R BOSE
-
依托单位:
Mechanism of oncogenesis by Rel/NF-kappaB
-
批准号:7006101
-
项目类别:
-
资助金额:$25.03万
-
财政年份:2003
-
负责人:HENRY R BOSE
-
依托单位:
Mechanism of oncogenesis by Rel/NF-kappaB
-
批准号:7161198
-
项目类别:
-
资助金额:$5.82万
-
财政年份:2003
-
负责人:HENRY R BOSE
-
依托单位:
Mechanism of oncogenesis by Rel/NF-kappaB
-
批准号:6831672
-
项目类别:
-
资助金额:$25.63万
-
财政年份:2003
-
负责人:HENRY R BOSE
-
依托单位:
Mechanism of oncogenesis by Rel/NF-kappaB
-
批准号:6557181
-
项目类别:
-
资助金额:$25.28万
-
财政年份:2003
-
负责人:HENRY R BOSE
-
依托单位:
Mechanism of oncogenesis by Rel/NF-kappaB
-
批准号:6917595
-
项目类别:
-
资助金额:$5.74万
-
财政年份:2003
-
负责人:HENRY R BOSE
-
依托单位:
Mechanism of oncogenesis by Rel/NF-kappaB
-
批准号:6694041
-
项目类别:
-
资助金额:$25.63万
-
财政年份:2003
-
负责人:HENRY R BOSE
-
依托单位:
Mechanism of oncogenesis by Rel/NF-kappaB
-
批准号:7161474
-
项目类别:
-
资助金额:$24.3万
-
财政年份:2003
-
负责人:HENRY R BOSE
-
依托单位:
Mechanism of oncogenesis by Rel/NF-kappaB
-
批准号:7341466
-
项目类别:
-
资助金额:$5.81万
-
财政年份:2003
-
负责人:HENRY R BOSE
-
依托单位:
TRAINING PROGRAM IN CANCER BIOLOGY
-
批准号:3533644
-
项目类别:
-
资助金额:$4.25万
-
财政年份:1988
-
负责人:HENRY R BOSE
-
依托单位:
TRAINING PROGRAM IN CANCER BIOLOGY
-
批准号:2085641
-
项目类别:
-
资助金额:$4.52万
-
财政年份:1988
-
负责人:HENRY R BOSE
-
依托单位:
TRAINING PROGRAM IN CANCER BIOLOGY
-
批准号:3533647
-
项目类别:
-
资助金额:$9.1万
-
财政年份:1988
-
负责人:HENRY R BOSE
-
依托单位:
TRAINING PROGRAM IN CANCER BIOLOGY
-
批准号:2712516
-
项目类别:
-
资助金额:$7.19万
-
财政年份:1988
-
负责人:HENRY R BOSE
-
依托单位:
TRAINING PROGRAM IN CANCER BIOLOGY
-
批准号:2894412
-
项目类别:
-
资助金额:$8.95万
-
财政年份:1988
-
负责人:HENRY R BOSE
-
依托单位:
TRAINING PROGRAM IN CANCER BIOLOGY
-
批准号:3533648
-
项目类别:
-
资助金额:$12.19万
-
财政年份:1988
-
负责人:HENRY R BOSE
-
依托单位:
TRAINING PROGRAM IN CANCER BIOLOGY
-
批准号:2429612
-
项目类别:
-
资助金额:$7.76万
-
财政年份:1988
-
负责人:HENRY R BOSE
-
依托单位:
TRAINING PROGRAM IN CANCER BIOLOGY
-
批准号:2085638
-
项目类别:
-
资助金额:$16.8万
-
财政年份:1988
-
负责人:HENRY R BOSE
-
依托单位:
TRAINING PROGRAM IN CANCER BIOLOGY
-
批准号:3533649
-
项目类别:
-
资助金额:$14.38万
-
财政年份:1988
-
负责人:HENRY R BOSE
-
依托单位:
TRAINING PROGRAM IN CANCER BIOLOGY
-
批准号:2085640
-
项目类别:
-
资助金额:$7.51万
-
财政年份:1988
-
负责人:HENRY R BOSE
-
依托单位:
FLUORESCENCE INVERTED MICROSCOPE-SCINTILLATION COUNTER
-
批准号:3523212
-
项目类别:
-
资助金额:$5.19万
-
财政年份:1987
-
负责人:HENRY R BOSE
-
依托单位:
海外基金